Literature DB >> 5000865

Chromomycin A 3 , an antitumor antibiotic: tissue distribution studies in mice as measured by microbial assay.

R F Pittillo, C Woolley.   

Abstract

A microbiological assay has been developed for chromomycin A(3), an antitumor antibiotic showing promise in human trials. The assay bacterium is a derived strain of Streptococcus faecalis resistant to methotrexate. Studies with mice revealed that relatively high concentrations of this antibiotic were maintained in the blood, kidneys, and liver of mice after a single-dose intraperitoneal injection of the drug.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5000865      PMCID: PMC376303          DOI: 10.1128/am.22.3.300-302.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Clinical experience with a new antitumor agent chromomycin.

Authors:  M KURU
Journal:  Cancer Chemother Rep       Date:  1961-07

2.  Further observations on the inhibiting effects of chromomycin A3 on transplantable tumors.

Authors:  K KAZIWARA; J WATANABE; T KOMEDA; T USUI
Journal:  Cancer Chemother Rep       Date:  1961-07

3.  Cytosine arabinoside sensitivity in actinobolin-resistant Streptococcus faecalis: the basis of a utilitarian microbiological assay.

Authors:  R F Pittillo; D E Hunt
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

Review 4.  Olivomycin, mithramycin, chromomycin: three related cancerostatic antibiotics.

Authors:  G F Gause
Journal:  Adv Chemother       Date:  1965
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.